Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality globally. The standard methods for assessing MSI and dMMR are polymerase chain reaction (PCR) and 4-antibody immunohistochemistry (IHC).